Champions Oncology Net Debt Growth & History (CSBR)
Champions Oncology's net debt was −$275,000 for fiscal 2026.
View full Champions Oncology company overviewChampions Oncology annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | −$275,000 | $3.2M | — |
| 2025 | 2025-04-30 | −$3.5M | −$8.6M | — |
| 2024 | 2024-04-30 | $5.2M | $6.6M | — |
| 2023 | 2023-04-30 | −$1.4M | −$1.9M | — |
| 2022 | 2022-04-30 | $531,000 | −$4.4M | −89.19% |
| 2021 | 2021-04-30 | $4.9M | $9.5M | — |
| 2020 | 2020-04-30 | −$4.5M | −$1.3M | — |
| 2019 | 2019-04-30 | −$3.2M | −$2.4M | — |
| 2018 | 2018-04-30 | −$813,000 | $2.4M | — |
| 2017 | 2017-04-30 | −$3.3M | −$731,000 | — |
| 2016 | 2016-04-30 | −$2.5M | — | — |
Champions Oncology quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | −$275,000 | $3.2M | — |
| Q3 2026 | 2026-01-31 | −$2.1M | −$5.6M | — |
| Q2 2026 | 2025-10-31 | −$3.1M | −$7.4M | — |
| Q1 2026 | 2025-07-31 | −$4.4M | −$8.9M | — |
| Q4 2025 | 2025-04-30 | −$3.5M | −$8.6M | — |
| Q3 2025 | 2025-01-31 | $3.5M | $219,000 | +6.69% |
| Q2 2025 | 2024-10-31 | $4.3M | $1.8M | +70.16% |
| Q1 2025 | 2024-07-31 | $4.5M | $1.1M | +30.61% |
| Q4 2024 | 2024-04-30 | $5.2M | $6.6M | — |
| Q3 2024 | 2024-01-31 | $3.3M | $6.0M | — |
| Q2 2024 | 2023-10-31 | $2.5M | $4.4M | — |
| Q1 2024 | 2023-07-31 | $3.5M | $2.3M | +198.12% |
| Q4 2023 | 2023-04-30 | −$1.4M | −$1.9M | — |
| Q3 2023 | 2023-01-31 | −$2.8M | −$3.7M | — |
| Q2 2023 | 2022-10-31 | −$1.9M | −$6.5M | — |
| Q1 2023 | 2022-07-31 | $1.2M | −$4.3M | −78.79% |
| Q4 2022 | 2022-04-30 | $531,000 | −$4.4M | −89.19% |
| Q3 2022 | 2022-01-31 | $931,000 | $1.9M | — |
| Q2 2022 | 2021-10-31 | $4.7M | $6.7M | — |
| Q1 2022 | 2021-07-31 | $5.5M | $5.8M | — |
| Q4 2021 | 2021-04-30 | $4.9M | $9.5M | — |
| Q3 2021 | 2021-01-31 | −$1.0M | −$1.7M | — |
| Q2 2021 | 2020-10-31 | −$2.0M | −$3.1M | — |
| Q1 2021 | 2020-07-31 | −$312,000 | −$2.1M | — |
| Q4 2020 | 2020-04-30 | −$4.5M | −$1.3M | — |
| Q3 2020 | 2020-01-31 | $686,000 | $3.8M | — |
| Q2 2020 | 2019-10-31 | $1.1M | $2.9M | — |
| Q1 2020 | 2019-07-31 | $1.8M | $2.6M | — |
| Q4 2019 | 2019-04-30 | −$3.2M | −$2.4M | — |
| Q3 2019 | 2019-01-31 | −$3.1M | −$2.0M | — |
| Q2 2019 | 2018-10-31 | −$1.8M | −$1.1M | — |
| Q1 2019 | 2018-07-31 | −$750,000 | −$353,000 | — |
| Q4 2018 | 2018-04-30 | −$813,000 | $2.4M | — |
| Q3 2018 | 2018-01-31 | −$1.0M | $2.4M | — |
| Q2 2018 | 2017-10-31 | −$631,000 | $3.6M | — |
| Q1 2018 | 2017-07-31 | −$397,000 | $4.0M | — |
| Q4 2017 | 2017-04-30 | −$3.3M | −$731,000 | — |
| Q3 2017 | 2017-01-31 | −$3.4M | — | — |
| Q2 2017 | 2016-10-31 | −$4.3M | — | — |
| Q1 2017 | 2016-07-31 | −$4.4M | — | — |
| Q4 2016 | 2016-04-30 | −$2.5M | — | — |
| Q3 2015 | 2015-01-31 | −$181,902 | — | — |
Champions Oncology net debt trends
Over the last five fiscal years, Champions Oncology's net debt decreased from $4.9M to −$275,000, a change of −$5.2M. The latest reported quarter, Q4 2026, shows −$275,000.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Champions Oncology source filings ↗